GLUCOSE MONITORING INSTRUMENT HAVING NETWORK CONNECTIVITY

Patent №

US 6,645,142

Granted

2003-11-11

Filed 2000

Owner

OPTISCAN BIOMEDICAL CORPORATION

Lab

AI components

1

evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09728743

A glucose monitoring instrument having network-based communication features which provide a link between patient and practitioner. The glucose monitoring instrument comprises circuitry for communicating data with one or more destination sites on the network which are configured to transmit and receive information to and from the instrument. Instrument measurements are transmitted over the link in addition to information and guidance, to provide increased accuracy, improved program compliance, and patient guidance from a supervisory authority or medical practitioner. In addition, a set of calibration features encourage calibration compliance.

Evolutionary computationA61B 5/0002G16H 40/40G16H 40/67G16Z 99/00A61B 5/14532Y10S 128/903Y10S 128/904

AI classification

Evolutionary computation0.85
Knowledge representation0.01
AI hardware0.00
Natural language0.00
Planning0.00
Speech0.00
Machine learning0.00
Vision0.00

Ownership

OPTISCAN BIOMEDICAL CORPORATION

assignment · 113360324

Assignors

BRAIG, JAMES R., HEWETT, GARY E., MUNROW, MICHAEL A., CORTELLA, JULIAN M., AZIZI, KAMRAVA, GOLDBERGER, DANIEL S.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC